logo
logo
Search For Features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
Market PulseMarket Pulse
ScreenersScreeners
MoreMore
prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector BoosterSector Booster
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
Economic CalendarEconomic Calendar
Aster DM Healthcare Ltd

Aster DM Healthcare

Large Cap•14,016 Employees•IPO 2018
Current Price
₹644.60
-10 (-1.53%)Updated
NSE :ASTERDM
BSE :540975
Sector :Health Care Providers & Services
Today's Range
₹612.60
₹644.60
union icon
₹652.70
52 Week Range
52W Low₹387.10
52W High₹732.20
₹644.60
union icon
Downside66.52%
Upside13.59%
chart iconChart

Price Chart

Compare with Peers

Historical Ratios

Track top 12 most important financial ratios

P/E Ratio: Price to Earnings - Most used valuation metric

Loading chart...

Analyzing Investment Quality

Processing 9 key metrics...

Key Metrics

Hover for details

Valuation

Market Cap
₹32,442.15 Cr
Market Cap
Total market value of company
P/E Ratio
99.14
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)
P/B Ratio
7.15
P/B Ratio
Price to Book Value. <3 may indicate undervaluation
EPS
₹6.41
EPS
Earnings Per Share. Higher and growing is positive

Profitability

ROE
4.75%
ROE
Return on Equity. >15% is good, >20% is excellent
ROCE
10.70%
ROCE
Return on Capital Employed. >15% is good
Net Margin
7.33%
Net Margin
Net profit as % of revenue. >10% is good
Operating Margin
-%
Operating Margin
Operating profit margin. >15% is good

Growth

EPS Growth (5Y)
81.35%
EPS Growth (5Y)
5-year EPS growth. >15% is strong
Revenue Growth (5Y)
-13.88%
Revenue Growth (5Y)
5-year revenue growth. >10% is good
Qtr Sales Growth
7.59%
Qtr Sales Growth
Quarter-over-quarter sales growth
Qtr Profit Growth
9.08%
Qtr Profit Growth
Quarter-over-quarter profit growth

Financial Health

Debt/Equity
0.59
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellent
Book Value
₹68.81
Book Value
Net asset value per share
Dividend Yield
-%
Dividend Yield
Annual dividend as % of price. >2% is good
Promoter Holding
40.40%
Promoter Holding
Promoter stake. >50% shows confidence
Good
Average
Needs Attention

SWOT Analysis

Strengths

5 points
  • •Robust quarterly sales (7.59%) and profit (9.08%) growth.
  • •Significant DII stake increase (8.99% to 26.32%) shows growing confidence.

Weaknesses

5 points
  • •High P/E ratio (109.66) suggests potential overvaluation compared to earnings.
  • •Significant quarterly EPS decline (-98.38%) raises immediate profitability concerns.

Opportunities

5 points
  • •Healthcare sector poised for significant growth from population and medical tourism.
  • •Potential for geographical expansion into underserved regions.

Threats

4 points
  • •Intense competition from established and emerging healthcare players.
  • •Significant FII holding decline (42.49% to 18.72%) signals reduced confidence.

Segment-wise Financial Analysis

Financial Results

Balance Sheet

Standalone • Annual • All amounts in ₹ Crores • CA Schedule III Format

No Balance Sheet Data Available

Standalone annual data is not available for this symbol.
Try switching to Consolidated view.

Shareholding Pattern

Loading shareholding data...

Company Insider Trading Activity

Recent Insider Transactions

Insider NameTransaction DateFiling DateTotal SharesChangePriceAction
Union Investments Private Limited
04 Mar 202507 Mar 202518.69 Cr
18.69 Cr
₹394BUY
Union (Mauritius) Holdings Limited
04 Mar 202507 Mar 20252.00 Cr
2.00 Cr
₹394BUY
Union Investments Private Limited
07 Mar 202511 Mar 20258.51 Cr
8.51 Cr
₹417.45BUY
Union (Mauritius) Holdings Limited
20 Mar 202525 Mar 20252.00 Cr
2.00 Cr
₹433BUY
Union Investments Private Limited
20 Mar 202525 Mar 202518.69 Cr
2.00 Cr
₹433BUY

Corporate Action

Company Announcements

Technical Analysis & Indicators

Standard pivot points - most widely used

Pivot Points (CLASSIC)

LevelPriceDistance% Change
R4₹740.87+₹96.27+14.93%
R3₹700.77+₹56.17+8.71%
R2₹676.73+₹32.13+4.99%
R1₹660.67+₹16.07+2.49%
PIVOT₹636.63-7.97-1.24%
CURRENT₹644.60--
S1₹540.37-₹104.23-16.17%
S2₹580.47-₹64.13-9.95%
S3₹596.53-₹48.07-7.46%
S4₹620.57-₹24.03-3.73%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: N/AP: N/ATC: N/A
R1
R2
R3
R4
indicator
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment

is trading CPR, indicating

● CPR Width

CPR is

● Opening Range

Day's range: ~

● Price Position

Trading Inside opening range

Delivery Volume Analysis & Trading Activity

Latest Volume
7.62L
(02 Mar 2026)
-10.8% vs avg
Delivery %
44.9%
(02 Mar 2026)
-3.5% vs avg
Avg Volume (20D)
8.55L
(03 Feb - 02 Mar)
20-day average
Avg Delivery %
48.5%
(03 Feb - 02 Mar)
Trend ↓
Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.

Peer Comparison & Industry Benchmarking

Quick Compare

Largest by Market Cap
Apollo Hospitals Enterprise Ltd
1.09L ₹ Cr
Best Profit Growth
Dr Agarwals Health Care Ltd
151.00 %
Highest Dividend Yield
Rainbow Childrens Medicare Ltd
0.51 %

Peer Comparison

Company Name
AGARWALEYE
Dr Agarwals Health Care Ltd
APOLLOHOSP
Apollo Hospitals Enterprise Ltd
FORTIS
Fortis Healthcare Ltd
HCG
Healthcare Global Enterprises Ltd
JLHL
Jupiter Life Line Hospitals Ltd
JSLL
KIMS
Krishna Institute of Medical Sciences Ltd
MAXHEALTH
Max Healthcare Institute Ltd
MEDANTA
Global Health Ltd
NH
Narayana Hrudayalaya Ltd
RAINBOW
Rainbow Childrens Medicare Ltd

About

ASTERDM

Aster DM Healthcare Ltd

Aster DM Healthcare Limited is a prominent healthcare provider operating across a wide geographical expanse. Its services span several countries in the Middle East and South Asia, including India, the United Arab Emirates, Qatar, Oman, Saudi Arabia, Jordan, Kuwait, Bahrain, and Mauritius. This extensive reach establishes Aster DM as a significant player in the international healthcare market, delivering services to a diverse patient population.

The company's business is structured around four key segments: Hospitals, Clinics, Retail Pharmacies, and Others. The Hospitals segment encompasses the operation of large-scale hospitals, often including integrated in-house pharmacies to provide comprehensive patient care within a single facility. Similarly, the Clinics segment focuses on smaller-scale clinics, also frequently with integrated pharmacies for convenient access to medications.

Aster DM's Retail Pharmacies segment represents a substantial portion of its business. This encompasses a network of both physical retail pharmacies and online pharmacy services, extending access to medications and healthcare products beyond the company's hospital and clinic settings. The addition of optical outlets further diversifies this segment, offering comprehensive eye care and related products to a wider customer base.

The "Others" segment encompasses a variety of supporting services and business activities. This includes healthcare consultancy, offering specialized advice and expertise to other healthcare organizations or institutions, as well as other ancillary services that support the core operations of the company’s hospital, clinic, and retail pharmacy networks. This diversified approach allows Aster DM to expand its revenue streams and offers opportunities for growth and strategic partnerships.

In summary, Aster DM Healthcare Limited's business model centers around providing a comprehensive range of healthcare services, from hospital-based care to retail pharmacy access, across multiple countries. Its diversified business structure, coupled with its international reach, positions the company for continued growth and influence in the global healthcare landscape. The company's long history, beginning in 1987, demonstrates its enduring commitment to delivering quality healthcare services and its ability to adapt and expand within a dynamic market.

COMPANY FACTS - ASTERDM

Registered Address

Awfis, 2nd Floor, Renaissance Centra, 27 & 27/1, Mission Road, Sampangi Rama Nagar

Bangalore

KARNATAKA

IN

Tel: 914846699999

Website:https://www.asterdmhealthcare.in/

Investor Relations:http://www.asterdmhealthcare.com/investors
Company Details

Group: Health Care Equipment & Services

Sector: Health Care

Industry: Health Care Providers & Services

Exchange: NATIONAL STOCK EXCHANGE OF INDIA

Employees: 14,016

IPO Date: 26/02/2018

MANAGEMENT - ASTERDM

Dr. Mandayapurath Azad Moopen

Executive Chairman of the Board, Managing Director

Mr. Sunil Kumar

Joint Chief Financial Officer

Mr. Amitabh Johri

Joint Chief Financial Officer

Mr. Ramesh Kumar

Chief Operating Officer

Mr. Sudeep Dey

Chief Information Security Officer

Mr. Hemish Purushottam

Compliance Officer, Company Secretary

Ms. Alisha Moopen

Deputy Managing Director, Executive Director

Mr. Shamsudheen Bin Mohideen Mammu Haji

Non-Executive Director

Mr. Anoop Moopen

Additional Non-Executive Non-Independent Director

Dr. Zeba Moopen

Additional Non-Executive Non-Independent Director

Mr. Thadathil Wilson

Non-Executive Director

Ms. Purana Deepti

Non-Executive Independent Director

Investor Questions Answered

Aster DM Healthcare Ltd (ASTERDM) Stock FAQs

Get answers to the most common questions about Aster DM Healthcare Ltd stock price, fundamentals, financial metrics, and investment analysis

The current share price of Aster DM Healthcare Ltd (ASTERDM) is ₹644.6. Today, the stock has declined by ₹10.00 (1.53%), trading in a range of ₹612.6 to ₹652.7. The stock opened at ₹618.2 with a trading volume of 7,62,213 shares.
Aster DM Healthcare Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹32,442.15 crores, P/E ratio of 99.14, ROE of 4.75%, and ROCE of 10.70%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Aster DM Healthcare Ltd (ASTERDM) is ₹732.2, while the 52-week low is ₹387.1. Currently trading at ₹644.6, the stock is 74.6% away from its 52-week low and 12.0% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Aster DM Healthcare Ltd stock at ₹644.6 depends on multiple factors. The stock is currently trading with a P/E ratio of 99.14 and P/B ratio of N/A. Today's performance shows a loss of 1.53%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Aster DM Healthcare Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹644.6, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Aster DM Healthcare Ltd's key financial metrics include: P/E Ratio: 99.14, P/B Ratio: N/A, ROE: 4.75%, ROCE: 10.70%, Dividend Yield: 0.00%, EPS: ₹6.41, Book Value: ₹68.81, Debt-to-Equity: 0.59, and Current Ratio: N/A. The company's market cap stands at ₹32,442.15 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Aster DM Healthcare Ltd stock opened at ₹618.2 and is currently trading at ₹644.6, showing a decline of ₹10.00 (1.53%). The intraday high is ₹652.7 and low is ₹612.6. The trading volume stands at 7,62,213 shares, indicating moderate market participation today.
Aster DM Healthcare Ltd has a Price-to-Earnings (P/E) ratio of 99.14, which means investors are willing to pay ₹99.14 for every ₹1 of earnings. With an EPS of ₹6.41, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
Aster DM Healthcare Ltd has a market capitalization of ₹32,442.15 crores, making it a mid-cap company. Market cap is calculated by multiplying the current stock price (₹644.6) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Aster DM Healthcare Ltd has a book value of ₹68.81 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹644.6, which is 836.8% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Aster DM Healthcare Ltd has a Return on Equity (ROE) of 4.75% and Return on Capital Employed (ROCE) of 10.70%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Aster DM Healthcare Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Aster DM Healthcare Ltd has a debt-to-equity ratio of 0.59, which measures the company's financial leverage by comparing total debt to shareholders' equity. This moderate ratio indicates balanced use of debt and equity. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Aster DM Healthcare Ltd has an Earnings Per Share (EPS) of ₹6.41, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹644.6 and P/E ratio of 99.14, investors are paying 99.14 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Aster DM Healthcare Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Aster DM Healthcare Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Aster DM Healthcare Ltd stock, consider: 1) Fundamental Analysis - Review P/E (99.14), ROE (4.75%), debt-to-equity (0.59), and growth rates. 2) Technical Analysis - Check 52-week range (₹387.10 - ₹732.20), moving averages, and chart patterns. 3) Valuation - Compare current price (₹644.60) with book value (₹68.81) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Aster DM Healthcare Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹644.6 is 6346x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Aster DM Healthcare Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹387.10 - ₹732.20). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.59 indicates leverage. 4) Liquidity Risk - Based on trading volume of 7,62,213 shares. 5) Valuation Risk - P/E of 99.14 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Aster DM Healthcare Ltd operates in the industry with key metrics: P/E ratio of 99.14, ROE of 4.75%, market cap of ₹32,442.15 crores, and dividend yield of 0.00%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.59), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Aster DM Healthcare Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹644.6, with a 52-week range of ₹387.10 to ₹732.20. Based on fundamentals like P/E (99.14), ROE (4.75%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Aster DM Healthcare Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹644.60. 2) Fundamental Deterioration - Declining ROE (currently 4.75%), increasing debt (D/E: 0.59), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Aster DM Healthcare Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.00%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.